Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Obesity is linked to more severe lower urinary tract symptoms.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Testosterone therapy increases bone density in older men with low testosterone levels.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.